ArticleACS pharmacology & translational science2021

Design, Synthesis, Pharmacokinetics, and Biodistribution of a Series of Bone-Targeting EP4 Receptor Agonist Prodrugs for Treatment of Osteoporosis and Other Bone Conditions.

Marion Thévenin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.